The history of Viagra, and its parent company copyright, presents a intriguing case study for investors. At first a blockbuster drug, generating billions in revenue , its exclusivity period created a flood of lower-priced alternatives , significantly eroding its dominance. While specific pharmaceutical companies may attempt to capitalize on similar